BlackRock, Inc.

Position in CRL — Charles River Laboratories International, Inc.

CIK 2012383 New York, NY

Position in CRL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$861,475,411

+$195,780,666 QoQ

Shares Held

3,798,560

-1.6% QoQ

Ownership

7.96%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 570 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $59,796,815,474 across 40 Diagnostics & Research names. CRL ranks #14 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	30,919,632	$15,501,866,689
2	DHR	Danaher Corp /De/	55,084,630	$10,492,520,314
3	IDXX	Idexx Laboratories Inc /De	8,170,178	$4,301,108,497
4	A	Agilent Technologies, Inc.	25,599,001	$3,400,315,293
5	ILMN	Illumina, Inc.	19,191,398	$3,374,423,500
6	WAT	Waters Corp /De/	8,484,939	$3,182,191,513
7	NTRA	Natera, Inc.	10,914,608	$2,962,770,335
8	IQV	Iqvia Holdings Inc.	14,549,693	$2,811,291,673

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$861,475,411	3,798,560	-1.6%	Shares	Sole	2026-08-07
2026-03-31	$665,694,745	3,859,100	+2.8%	Shares	Sole	2026-05-13
2025-12-31	$748,918,525	3,754,354	-2.6%	Shares	Sole	2026-02-12
2025-09-30	$603,320,079	3,856,066	+5.5%	Shares	Sole	2025-11-12
2025-06-30	$554,744,899	3,656,132	-0.4%	Shares	Sole	2025-08-12
2025-03-31	$552,532,571	3,670,825	-13.3%	Shares	Sole	2025-05-02
2024-12-31	$781,258,574	4,232,170	-0.1%	Shares	Sole	2025-02-07
2024-09-30	$834,825,034	4,238,336	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.